Wednesday, May 15, 2024
Facebook Linkedin Twitter
HomeTagsCetuximab

Cetuximab

Biotechnology

Jacobio Pharma to Collaborate with Merck on Clinical Trial of JAB-21822

PR Newswire -
Jacobio announced it has entered into a clinical trial collaboration agreement with Merck on clinical study of combination therapy between Jacobio's KRAS G12C inhibitor...
Biotechnology

Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China

PR Newswire -
Jacobio Pharmaceuticals announced that its KRAS G12C inhibitor JAB-21822 completed the first patient dosing in combination therapy with Cetuximab at Peking University Cancer Hospital...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us